glp-1 weight loss clinical trials GLP1 agonists: current and future landscape of for patients with metabolic dysfunction Obesity Clinical Trials | Expert

GIP and GLP-1, the two incretin hormones: Similarities and differences

Waiting until your weight holds steady is not a delay, it is part of getting a result that does not shift

Until recently, the most effective new obesity medications, including semaglutide (Wegovy) and tirzepatide (Zepbound), were available only as injectables

In order to develop exendin-4 as a drug Amylin set about synthesising the peptide from the Gila monster and then testing it

476 If SGLT2 inhibitors and GLP-1RAs are effective in patients with heart failure (regardless of whether the ejection fraction is reduced or preserved), the commonalities between the two types of heart failure may be greater than is often thought